Cellular senescence in ischemia/reperfusion injury

Area of Science:

• Biomedical Science
• Pathophysiology
• Regenerative Medicine

Background:

• Ischemia/reperfusion (IR) injury is a significant global health burden, affecting multiple organs.
• Accumulation of senescent cells post-IR injury contributes to the transition from acute to chronic organ damage.
• Cellular senescence is increasingly recognized as a key mechanism in IR-induced pathology.

Purpose of the Study:

• To review the mechanisms by which cellular senescence drives IR injury.
• To highlight recent advances in targeting senescent cells for IR injury treatment.
• To discuss future research directions in senotherapeutics for multi-organ IR.

Main Methods:

• Literature review of recent studies on cellular senescence and IR injury.
• Analysis of basic and clinical research on senolytic therapies for IR.
• Synthesis of current understanding and future perspectives.

Main Results:

• Senescent cells play a pivotal role in the progression of acute IR injury to chronic disease.
• Targeting senescent cells demonstrates potential for preventing and treating IR-induced organ damage.
• Emerging senotherapeutics show promise in preclinical and clinical settings for IR injury.

Conclusions:

• Cellular senescence is a critical mediator in IR injury, linking acute damage to chronic conditions.
• Therapeutic strategies targeting senescent cells offer a novel approach for managing multi-organ IR injuries.
• Further research into senotherapeutics is crucial for developing effective treatments for IR-related diseases.